Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664248 · ClinicalTrials.gov registry record · Phase 3
A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
A Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,414
- Enrollment target
NCT00664248 is a Phase 3 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 1,414 participants.
The verdict
NCT00664248, a Phase 3 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,414 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Interventions
- DRUG Clindamycin
- DRUG Vehicle
- DRUG Benzoyl peroxide
- DRUG IDP-110
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,414 participants |
| Start Date | 2006-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00664248
The ClinicalTrials.gov registry entry for NCT00664248 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,414 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dow Pharmaceutical Sciences, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Clindamycin is the first listed.
NCT00664248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00664248 about?
NCT00664248 is a clinical study titled "A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris". The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
What is the current status of trial NCT00664248?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,414 participants. The study started on 2006-10.
What interventions are being tested in trial NCT00664248?
The interventions under investigation include: Clindamycin (DRUG), Vehicle (DRUG), Benzoyl peroxide (DRUG), IDP-110 (DRUG).
Who is sponsoring clinical trial NCT00664248?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.